599 related articles for article (PubMed ID: 28444227)
1. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.
Cagney DN; Martin AM; Catalano PJ; Redig AJ; Lin NU; Lee EQ; Wen PY; Dunn IF; Bi WL; Weiss SE; Haas-Kogan DA; Alexander BM; Aizer AA
Neuro Oncol; 2017 Oct; 19(11):1511-1521. PubMed ID: 28444227
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.
Martin AM; Cagney DN; Catalano PJ; Warren LE; Bellon JR; Punglia RS; Claus EB; Lee EQ; Wen PY; Haas-Kogan DA; Alexander BM; Lin NU; Aizer AA
JAMA Oncol; 2017 Aug; 3(8):1069-1077. PubMed ID: 28301662
[TBL] [Abstract][Full Text] [Related]
3. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study.
Huang JF; Shen J; Li X; Rengan R; Silvestris N; Wang M; Derosa L; Zheng X; Belli A; Zhang XL; Li YM; Wu A
Ann Transl Med; 2020 Apr; 8(7):482. PubMed ID: 32395526
[TBL] [Abstract][Full Text] [Related]
4. Incidence, prevalence, and outcomes of systemic malignancy with bone metastases.
Jiang W; Rixiati Y; Zhao B; Li Y; Tang C; Liu J
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020915989. PubMed ID: 32634071
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
Chen QF; Huang T; Shen L; Li W
PLoS One; 2019; 14(1):e0209293. PubMed ID: 30601858
[TBL] [Abstract][Full Text] [Related]
6. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
7. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.
Ascha MS; Ostrom QT; Wright J; Kumthekar P; Bordeaux JS; Sloan AE; Schumacher FR; Kruchko C; Barnholtz-Sloan JS
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):917-925. PubMed ID: 31053636
[TBL] [Abstract][Full Text] [Related]
8. Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.
Davis FG; Dolecek TA; McCarthy BJ; Villano JL
Neuro Oncol; 2012 Sep; 14(9):1171-7. PubMed ID: 22898372
[TBL] [Abstract][Full Text] [Related]
9. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
Cheng S; Yang L; Dai X; Wang J; Han X
BMC Cancer; 2021 Sep; 21(1):1057. PubMed ID: 34563149
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients.
Budnik J; Suri J; Bates JE; Bylund KC; Milano MT
Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk Factors, and Prognosis of Patients with Hepatocellular Carcinoma and Brain Metastases.
Feng JC; He Y; Polychronidis G; Xin J; You S; Xiong J
Curr Med Sci; 2024 Feb; 44(1):180-186. PubMed ID: 38393527
[TBL] [Abstract][Full Text] [Related]
12. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
14. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
15. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of brain metastases and leptomeningeal disease.
Lamba N; Wen PY; Aizer AA
Neuro Oncol; 2021 Sep; 23(9):1447-1456. PubMed ID: 33908612
[TBL] [Abstract][Full Text] [Related]
18. Survival benefits of primary tumor surgery for synchronous brain metastases: A SEER-based population study with propensity-matched comparative analysis.
Zhang C; Zhang Y; Li D; Jia W
Cancer Med; 2023 Feb; 12(3):2677-2690. PubMed ID: 35965407
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
20. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
